Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05455814 · ClinicalTrials.gov registry record · NA
Brain Health With Inner Engineering Meditation
A NA study of Meditation and Brain; Agenesis, sponsored by Beth Israel Deaconess Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT05455814: Recruiting NA study of Meditation and Brain; Agenesis, sponsored by Beth Israel Deaconess Medical Center.
NCT05455814 is a NA study of Meditation and Brain; Agenesis that is actively recruiting participants, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05455814, a NA study of Meditation and Brain; Agenesis, is actively recruiting participants, sponsored by Beth Israel Deaconess Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will explore whether a 21-minute meditation practice called Shambhavi Mahamudra Kriya leads to changes in brain health and explore how it affects cognitive and physiological function.
Primary Outcome
Frontal Midline Theta Power is obtained from an average of 8 electrodes (Fpc, Fc, Cz, Pz, Oz, F7, F8, P7, P8) around the midline in a standard EEG cap and has been proposed as a correlate of meditation success in previous studies. Increased value suggests increased control over the brain's default mode network, suggesting more successful meditation experience.
Conditions Studied
Interventions
- BEHAVIORAL Shambhavi Madamudra Kriya
Study Locations (1)
Massachusetts
- Beth Israel Deaconess Medical Centre - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2023-01-06 |
| Est. Completion | 2025-12 |
| Phase | NA |
What NCT05455814 shows while recruiting
NCT05455814 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Meditation appearing as the primary indexed condition, and to 1 intervention - of which Shambhavi Madamudra Kriya is the first listed.
NCT05455814 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05455814 about?
NCT05455814 is a clinical study titled "Brain Health With Inner Engineering Meditation". This study will explore whether a 21-minute meditation practice called Shambhavi Mahamudra Kriya leads to changes in brain health and explore how it affects cognitive and physiological function.
What is the current status of trial NCT05455814?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2023-01-06. Estimated completion is 2025-12.
What conditions does trial NCT05455814 study?
This clinical trial studies the following conditions: Meditation, Brain; Agenesis.
What interventions are being tested in trial NCT05455814?
The interventions under investigation include: Shambhavi Madamudra Kriya (BEHAVIORAL).
Who is sponsoring clinical trial NCT05455814?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05455814 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Meditation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05455814's enrollment target sits among peer trials
80 994th of 2000 higher than 941 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI